2024 - Accelerating Clinical Development through Design, Diversity & Digitalization in Oncology and Beyond

In this dynamic panel-type webinar, the expert speakers will explore how to speed drug development and improve return on investment (ROI) by adopting a “3-D” approach to trials focusing on design, diversity and digitalization.
Oncology trials present unique challenges and will be the focal point for this discussion, but the key insights the speakers will cover are applicable to a wide range of therapeutic areas. Therefore, attendance is recommended across all therapeutic areas, ranging from cardiovascular to neuroscience to rare disease and, in fact, any enrollment-challenged indications.
The need to improve geographical, racial, ethnic and other forms of diversity and inclusion in trials — including new legislation and regulatory guidance documents to spur adoption of diverse trials — has been at the forefront of the industry for several years.
Read more...
Register for this webinar today to gain insights into innovative approaches to keeping clinical development on track to meet timelines and other KPIs.
Keywords: Clinical Trial Design, Inclusion, DCTs, DHT, Rare Diseases/Orphan Drugs, Sites, Decentralized Clinical Trials, AI, Artificial Intelligence, Diversity, Digital Health Technology, Clinical Trials, Therapeutic Areas, Patient Advocacy Groups, Patient Recruitment, Oncology, CRO, Patient-Centricity, Clinical Research, Drug Development, Rare Disease